NDC 37012-098-50 - Skopko Urinary Pain Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 37012-098
- Requested NDC
- 37012-098-50
- Package NDCs from labels
- 37012-098-50, 37012-098-01, 37012-098-30
- Manufacturer
- Skopko | Reese Pharmaceutical Co
- Effective date
- 2024-12-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Skopko Urinary Pain Relief - Skopko | Reese Pharmaceutical Co | Skopko | Reese Pharmaceutical Co | 2024-12-18 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 37012-098-01 | Skopko Urinary Pain Relief | 1 in 1 CARTON | TABLET | 1 | 4 | |
| 37012-098-30 | Skopko Urinary Pain Relief | 30 in 1 CELLO PACK | TABLET | 30 | 4 | |
| 37012-098-50 | Skopko Urinary Pain Relief | 32 in 1 CELLO PACK | TABLET | 32 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 49baf6e5-133a-4e1a-9740-506673d27caf | 2026-08-21 | Warnings, Adverse reactions | 0EWG668W17 |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | c0e5d32e-075f-4c76-8332-a06560001efe | 2026-08-14 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | 132cc592-6b03-4b75-bf39-df476fb9dc81 | 2026-08-14 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc | 96308f8c-66e7-486a-a5c0-ee9a133ad051 | 2026-08-14 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ce702be2-eec2-4346-965e-f1f6ba342fc9 | 2026-08-14 | Warnings, Adverse reactions | 0EWG668W17 |
| Dr. Shitong Photon Energy Eye Care Liquid | TETRAHYDROZOLINE HCL 0.05% HYPROMELLOSE 0.3% DR. SHITONG PHOTON ENERGY EYE CARE LIQUID | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 58ace434-55ef-17ef-e063-6294a90aa878 | 2026-08-10 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | REMEDYREPACK INC. | f6829698-b12e-484d-a322-d2f68586e637 | 2026-08-07 | Adverse reactions | 0EWG668W17 |
| Gencare-Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | Pioneer Life Sciences, LLC | 6bbf15b4-2954-40ff-8460-1ef0ed890654 | 2026-08-03 | Warnings | 0EWG668W17 |
| Nuvicare-Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | NUVICARE LLC | 5fe4e4dc-f1c4-4617-b6a6-6ea16a63abfe | 2026-08-03 | Warnings | 0EWG668W17 |
| Cystex Max Strength UTI Pain Relief | CYSTEX MAX STRENGTH UTI PAIN RELIEF | Clarion Brands LLC | 57482f71-80d3-b20d-e063-6394a90a0cf4 | 2026-07-27 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 6eb59b69-4ad0-47b1-bd3c-1d04d0852ec5 | 2026-07-27 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 56ad921f-0b6e-aa2b-e063-6394a90aec6b | 2026-07-15 | Warnings, Adverse reactions | 0EWG668W17 |
| PHENAZOPYRIDINE HYDROCHLORIDE | PHENAZOPYRIDINE HYDROCHLORIDE | Genus Lifesciences Inc. | 991b3b97-9cea-4c48-90a4-ebff55417d98 | 2026-07-14 | Adverse reactions | 0EWG668W17 |
| Artificial Tears | ARTIFICIAL TEARS | AvPAK | f18bebf2-1936-658f-e053-2a95a90a5012 | 2026-07-07 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 7e131f69-d259-404d-a859-0497f5cbe856 | 2026-06-24 | Adverse reactions | 0EWG668W17 |
| Rohto Sun and Sport | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 8bcc8882-b886-4b55-9bc4-d4b92a41358f | 2026-06-19 | Warnings | 3NXW29V3WO |
| Rohto Dual Light Relief | HYPROMELLOSE, POVIDONE | The Mentholatum Company | 1b597f83-d7f1-cf93-e063-6394a90a99f7 | 2026-06-19 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 548edf26-c81e-f982-e063-6394a90af9da | 2026-06-18 | Warnings, Adverse reactions | 0EWG668W17 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.